Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit
CD133 (prominin 1) is widely viewed as a cancer stem cell marker in association with drug resistance and cancer recurrence. Herein, we report that with impaired RTK-Shp2-Ras-Erk signaling, heterogenous hepatocytes form clusters that manage to divide during mouse liver regeneration. These hepatocytes...
Main Authors: | Kota Kaneko, Yan Liang, Qing Liu, Shuo Zhang, Alexander Scheiter, Dan Song, Gen-Sheng Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/86824 |
Similar Items
-
<i>BRAF</i> Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale
by: Jillian Wilhelmina Paulina Bracht, et al.
Published: (2019-09-01) -
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function
by: Marc Dorenkamp, et al.
Published: (2023-02-01) -
CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro
by: Ming Liu, et al.
Published: (2023-10-01) -
The Role of Protein Tyrosine Phosphatases in Inflammasome Activation
by: Marianne R. Spalinger, et al.
Published: (2020-07-01) -
Non-Classical Intercellular Communications: Basic Mechanisms and Roles in Biology and Medicine
by: Natalia Polyakova, et al.
Published: (2023-03-01)